---
pmid: '31116475'
title: Mutations in KARS cause a severe neurological and neurosensory disease with
  optic neuropathy.
authors:
- Scheidecker S
- Bär S
- Stoetzel C
- Geoffroy V
- Lannes B
- Rinaldi B
- Fischer F
- Becker HD
- Pelletier V
- Pagan C
- Acquaviva-Bourdain C
- Kremer S
- Mirande M
- Tranchant C
- Muller J
- Friant S
- Dollfus H
journal: Hum Mutat
year: '2019'
full_text_available: false
doi: 10.1002/humu.23799
---

# Mutations in KARS cause a severe neurological and neurosensory disease with optic neuropathy.
**Authors:** Scheidecker S, Bär S, Stoetzel C, Geoffroy V, Lannes B, Rinaldi B, Fischer F, Becker HD, Pelletier V, Pagan C, Acquaviva-Bourdain C, Kremer S, Mirande M, Tranchant C, Muller J, Friant S, Dollfus H
**Journal:** Hum Mutat (2019)
**DOI:** [10.1002/humu.23799](https://doi.org/10.1002/humu.23799)

## Abstract

1. Hum Mutat. 2019 Oct;40(10):1826-1840. doi: 10.1002/humu.23799. Epub 2019 Jun
18.

Mutations in KARS cause a severe neurological and neurosensory disease with 
optic neuropathy.

Scheidecker S(1)(2), Bär S(3), Stoetzel C(1), Geoffroy V(1), Lannes B(4), 
Rinaldi B(3), Fischer F(3), Becker HD(3), Pelletier V(5), Pagan C(6), 
Acquaviva-Bourdain C(6), Kremer S(7), Mirande M(8), Tranchant C(9), Muller 
J(1)(2), Friant S(2), Dollfus H(1)(5).

Author information:
(1)Laboratoire de Génétique Médicale, INSERM U1112, Institut de Génétique 
Médicale d'Alsace, Université de Strasbourg, Strasbourg, France.
(2)Laboratoires de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, 
Strasbourg, France.
(3)Laboratoire de Génétique Moléculaire, Génomique, Microbiologie (GMGM), 
UMR7156, Université de Strasbourg, CNRS, Strasbourg, France.
(4)Service d'Anatomo-pathologie, Hôpitaux Universitaires de Strasbourg, Hôpital 
de Hautepierre, Strasbourg, France.
(5)Centre de Référence pour les affections rares en génétique ophtalmologique, 
CARGO, Filière SENSGENE, Hôpitaux Universitaires de Strasbourg, Strasbourg, 
France.
(6)Service de Biochimie et Biologie Moléculaire, Centre de Biologie et de 
Pathologie Est, Hospices Civils de Lyon, Lyon, France.
(7)Service de Neuroradiologie/Imagerie 2, CHU de Strasbourg, Hôpital de 
Hautepierre, Strasbourg, France.
(8)Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, University 
Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette, France.
(9)Service de Neurologie Hôpitaux Universitaires de Strasbourg, Hôpital de 
Hautepierre, Strasbourg, France.

Mutations in genes encoding aminoacyl-tRNA synthetases have been reported in 
several neurological disorders. KARS is a dual localized lysyl-tRNA synthetase 
and its cytosolic isoform belongs to the multiple aminoacyl-tRNA synthetase 
complex (MSC). Biallelic mutations in the KARS gene were described in a wide 
phenotypic spectrum ranging from nonsyndromic deafness to complex impairments. 
Here, we report on a patient with severe neurological and neurosensory disease 
investigated by whole-exome sequencing and found to carry biallelic mutations 
c.683C>T (p.Pro228Leu) and c.871T>G (p.Phe291Val), the second one being novel, 
in the KARS gene. The patient presented with an atypical clinical presentation 
with an optic neuropathy not previously reported. At the cellular level, we show 
that cytoplasmic KARS was expressed at a lower level in patient cells and 
displayed decreased interaction with MSC. In vitro, these two KARS variants have 
a decreased aminoacylation activity compared with wild-type KARS, the 
p.Pro228Leu being the most affected. Our data suggest that dysfunction of 
cytoplasmic KARS resulted in a decreased level of translation of the 
nuclear-encoded lysine-rich proteins belonging to the respiratory chain complex, 
thus impairing mitochondria functions.

© 2019 Wiley Periodicals, Inc.

DOI: 10.1002/humu.23799
PMID: 31116475 [Indexed for MEDLINE]
